000 01607 a2200457 4500
005 20250517095315.0
264 0 _c20170303
008 201703s 0 0 eng d
022 _a1348-4540
024 7 _a10.1507/endocrj.EJ16-0064
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIto, Yasuhiro
245 0 0 _aTyrosine-kinase inhibitors to treat radioiodine-refracted, metastatic, or recurred and progressive differentiated thyroid carcinoma [Review].
_h[electronic resource]
260 _bEndocrine journal
_cJul 2016
300 _a597-602 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aDisease Progression
650 0 4 _aHumans
650 0 4 _aIodine Radioisotopes
_xtherapeutic use
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aThyroid Neoplasms
_xdrug therapy
650 0 4 _aTreatment Failure
700 1 _aSuzuki, Shinichi
700 1 _aIto, Ken-Ichi
700 1 _aImai, Tsuneo
700 1 _aOkamoto, Takahiro
700 1 _aKitano, Hiroya
700 1 _aSugitani, Iwao
700 1 _aSugino, Kiminori
700 1 _aTsutsui, Hidemitsu
700 1 _aHara, Hisato
700 1 _aYoshida, Akira
700 1 _aShimizu, Kazuo
773 0 _tEndocrine journal
_gvol. 63
_gno. 7
_gp. 597-602
856 4 0 _uhttps://doi.org/10.1507/endocrj.EJ16-0064
_zAvailable from publisher's website
999 _c26046493
_d26046493